Telemetrix, the premier provider of remote patient monitoring solutions, announced a partnership with Rx.Health recently. The partnership will allow healthcare providers to prescribe remote physiological monitoring (RPM) and remote therapeutic monitoring (RTM)...
To supplement the existing suite of Remote Physiological Monitoring (RPM) codes authorized by Medicare, the Centers for Medicare & Medicaid Services (CMS) has suggested a new category of digital health services called Remote Therapeutic Monitoring/Treatment...
Reluctance of people to receive safe available vaccines, known as ‘vaccine hesitancy’, was already a growing concern before the COVID-19 pandemic but it never hit us as hard until recently. As COVID-19 vaccination programs across the country transition from meeting...
The current COVID-19 crisis across the globe has posed a multitude of challenges to healthcare systems worldwide. One of most important challenges is to safely maintain continuity of care for their patients while dealing with the risk and burden of the pandemic. In...
Today, every practice needs a digital front door that is not only secure but can also convert existing appointments into video visits while seamlessly onboarding and tracking patients' healthcare needs, as well as providing support billing and much more! ...
Dedalus Group, one of the world's largest Healthcare Software companies, is transforming healthcare across the entire care continuum. It has formed a strategic alliance with Rx.Health in North America. The collaboration will enable Dedalus' solution, Digital Connect...
Rx.Health created the first enterprise-wide EHR-integrated digital formulary and has formed a strategic partnership with LiveCare, a leading provider of Remote Patient Monitoring systems.The digital health companies have successfully completed integration between...
Social Determinants of Health (SDoH) are factors such as income, education, and home/work environment that influence health outcomes and life expectancy. SDoH are defined by the World Health Organization as “the conditions in which people are born, grow, live, work...
Hospital at Home (H@H) is a revolutionary model for delivering hospital-level, patient-centric, individualized care for patients at home via remote patient monitoring. Although other nations, such as England, Israel, and Australia, have already used the model, the...
Vaccination is a key tool to help end the COVID-19 pandemic. As of December 2020, the Pfizer and Moderna vaccines have been FDA authorized and recommended for the prevention of COVID-19 in the United States. However, this approval has raised many questions about the...
Rick Strobridge, Rx.Health CEO will chair a session entitled "The Second Wave: Are We Ready?" at the Node Health conference. The session will highlight five key takeaways digital health system leaders learned during initial Covid response efforts. We will gain...
We are proud to share that Rx.Health work on digital monitoring and employee wellness has been highlighted in NEJM Catalyst Nov, 2020 issue among the top five take aways from digital Health leaders during COVID. All across Covid-19, health staff have been forced to...
Rx.Health, a company formed to commercialize technology from the Mount Sinai Health System and the first to bring an enterprise-wide platform to prescribe Digital Medicine and Digital Therapeutics (DTx), announced today the appointment of Richard Strobridge as its...
We are super thrilled to be selected among the top 5 digital health companies to reduce costs and improve outcomes for both payers and providers. In the presentation, our CEO Richard Strobridge will be sharing: Our EHR connected digital health platform and approach to...
No vaccines have been approved for the prevention of COVID-19. There are currently more than 169 candidates undergoing development and 26 in the clinical development stage according to WHO. An ideal vaccine against SARS-CoV-2 would be effective after one or two...
Rx.Health's TrialEngage™ Virtual Trial Toolkit is Selected by the American Gastroenterological Association to Speed GITrials and Create Nationwide Clinical Trial Network With our partners, we have developed a unique ecosystem to support centres for excellence in...
COVAXIN™, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of Virology (NIV). The indigenous, inactivated vaccine is developed and manufactured in...
The broad-spectrum antiviral agent remdesivir (GS-5734; Gilead Sciences, Inc) is an inhibitor of the viral RNA-dependent, RNA polymerase with inhibitory activity against SARS-CoV and the Middle East respiratory syndrome (MERS-CoV). The US FDA issued EUA (Emergency use...
We promise we don’t send spam
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication
Submit your details to get access to the publication